|
|
|
|
Efficacy and Safety of Dolutegravir/Lamivudine (DTG/3TC) in Antiretroviral Therapy (ART)-Naive Adolescents Living With HIV-1: DANCE Study Week 96 Results
|
|
|
IAS 2023 july 26
Thanyawee Puthanakit,1 Linda Aurpibul,2 Monica Lopez,3 Cindy Vavro,3 Gilda Bontempo,4 Kishen Morarji,5 Marika Ciuffa,5 Tatini Chakraborty,6
Ann Buchanan,3 Lionel Tan7
1Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; 3ViiV Healthcare, Durham, NC, USA; 4ViiV Healthcare, Branford, CT, USA; 5GSK, Brentford, UK; 6GSK, Bangalore, Karnataka, India; 7ViiV Healthcare, Brentford, UK
|
|
|
|
|
|
|